Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP) Price Prediction & Forecast

$0.055

-0.008 (-15.15%)At close

Price Predictions

1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

ADAP stock price ended at $0.05 on Monday, after losing -15.15%

Adaptimmune Therapeutics PLC (ADAP) last closed at $0.0549, losing -15.15%. These facts feed the 1-day and 1-week ADAP price prediction above.

Analyst Consensus

Adaptimmune Therapeutics PLC (ADAP): 6 buy, 1 hold, 1 sell. Outlook: Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Strong buy
Sell
1
Buy
6

Forecast Drivers

Adaptimmune Therapeutics PLC (ADAP) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Seasonality analysis for ADAP

Historically the probability of a positive August return for ADAP is 51.16%. February offers the highest probability of a positive month at 51.28%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for ADAP

MonthMin PriceAvg PriceMax PricePotential ROI
Aug 2026$0.56$0.60$0.71+984.85%
Sep 2026$0.55$0.64$0.68+1069.16%
Oct 2026$0.81$0.88$1.08+1505.07%
Nov 2026$0.78$0.88$0.92+1505.07%
Dec 2026$0.68$0.88$1.10+1505.07%

In 2026, Adaptimmune Therapeutics PLC (ADAP) is projected to range from $0.55 to $1.10.

Adaptimmune Therapeutics PLC 2026 monthly forecast

Aug 2026 ADAP forecast
Potential ROI: 984.85%

In Aug 2026, Adaptimmune Therapeutics PLC is projected to average $0.60, with a low of $0.56 and high of $0.71.

Sep 2026 ADAP forecast
Potential ROI: 1069.16%

In Sep 2026, Adaptimmune Therapeutics PLC is projected to average $0.64, with a low of $0.55 and high of $0.68.

Oct 2026 ADAP forecast
Potential ROI: 1505.07%

In Oct 2026, Adaptimmune Therapeutics PLC is projected to average $0.88, with a low of $0.81 and high of $1.08.

Nov 2026 ADAP forecast
Potential ROI: 1505.07%

In Nov 2026, Adaptimmune Therapeutics PLC is projected to average $0.88, with a low of $0.78 and high of $0.92.

Dec 2026 ADAP forecast
Potential ROI: 1505.07%

In Dec 2026, Adaptimmune Therapeutics PLC is projected to average $0.88, with a low of $0.68 and high of $1.10.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started